# FDA Inspection 1218897 - KDNA Life Sciences LLC - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/kdna-life-sciences-llc/e3de19c8-308e-4160-b7a9-b8c68ae90fe8
Source feed: FDA_Inspections

> FDA Inspection 1218897 for KDNA Life Sciences LLC on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218897
- Company Name: KDNA Life Sciences LLC
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1218897 - 2023-09-15](https://www.keypedia.com/records/fda_inspections/kdna-life-sciences-llc/e9904d68-911d-488b-a3b5-1a466249c36d)
- [FDA Inspection 816876 - 2013-02-01](https://www.keypedia.com/records/fda_inspections/kdna-life-sciences-llc/60f6ebaf-cfb0-4123-9ac7-b63864ec8b3c)
- [FDA Inspection 668816 - 2010-06-24](https://www.keypedia.com/records/fda_inspections/kdna-life-sciences-llc/88ce9f6f-82d9-427a-8d67-11bd258455d2)

Company: https://www.keypedia.com/companies/kdna-life-sciences-llc/dd13caf2-1129-42d7-a16c-51419830bd9a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d